Clinical Trials Browser

Phase 2 × OTHER × Escitalopram × Clear all

NCT05289830 2025-12-10

Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

Phase 2 Terminated

4 enrolled 10 charts

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT03728673 2025-06-22

A Study Utilizing Escitalopram in Glioma Patients

Phase 2 Recruiting

Glioma

NCT03010761 2019-07-24

Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer

Phase 2 Terminated

Behavior, Addictive